Look ahead: Retail sales; GDP; EnQuest; Walgreens Boots Alliance
Germany and Australia release retail sales. Watch out for the final GDP growth rate print from the UK and the US. EnQuest releases full-year earnings.
Plus, Walgreens Boots Alliance commentary around its healthcare services will be key as it reports quarterly earnings.
(AI Video Summary)
Expected economic data
In this video, Angeline Ong talks about what's happening in the markets on Thursday, 28 March. She starts by discussing the retail sales report in Australia, where people are curious to know if prices are going up or if the central bank has been successful in keeping them under control. In Germany, the main things to keep an eye on are the retail sales report and the unemployment rate.
In the UK, people will be paying attention to the final reading of the GDP growth rate and the details of car production in February. The GDP growth rate in the US is also important, along with initial jobless claims, the Chicago PMI, and pending home sales.
Ong shows a chart of the US 500 index and explains that even though people were expecting a decline, it has actually been rising since October. As the long holiday weekend is coming up, there probably won't be any big news, and many investors might play it safe and wait until after the holiday to get back into the market.
Earnings reports
Ong also mentions a few noteworthy companies' earnings reports for the week, like EnQuest, SSE, and Walgreens Boots Alliance. She points out that Walgreens Boots Alliance's share price has gone down, and she discusses how a cyber attack on its Insura United Health Unit has affected the company. She also talks about their focus on making more money through healthcare services.
This information has been prepared by IG, a trading name of IG Markets Limited. In addition to the disclaimer below, the material on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication. Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients. See full non-independent research disclaimer and quarterly summary.
Act on share opportunities today
Go long or short on thousands of international stocks with spread bets and CFDs.
- Get full exposure for a comparatively small deposit
- Trade on spreads from just 0.1%
- Get greater order book visibility with direct market access
See opportunity on a stock?
Try a risk-free trade in your demo account, and see whether you’re on to something.
- Log in to your demo
- Take your position
- See whether your hunch pays off
See opportunity on a stock?
Don’t miss your chance – upgrade to a live account to take advantage.
- Trade a huge range of popular stocks
- Analyse and deal seamlessly on fast, intuitive charts
- See and react to breaking news in-platform
See opportunity on a stock?
Don’t miss your chance. Log in to take advantage while conditions prevail.
Live prices on most popular markets
- Equities
- Indices
- Forex
- Commodities
Prices above are subject to our website terms and agreements. Prices are indicative only. All share prices are delayed by at least 15 minutes.
Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 15 mins.
